Patient Involvement and Satisfaction with Setting Treatment Goals for Patients with Psoriatic Arthritis: Findings from the "Closer Together" Survey
Author(s)
Betteridge N1, Hill J2, Guerreiro M3, Tietz N4, El Baou C5, Reed C5
1Neil Betteridge Associates, London, UK, 2Eli Lilly and Company, Basingstoke, IN, UK, 3Lilly Portugal, Lisbon, Portugal, 4Lilly Deutschland GmbH, Bad Homburg, Germany, 5Eli Lilly and Company, Windlesham, UK
OBJECTIVES : To describe involvement and satisfaction with setting treatment goals in a subset of PsO patients with co-morbid psoriatic arthritis (PsA) from the ‘Closer Together’ survey. METHODS : ‘Closer Together’ was an international online survey to map perception and satisfaction towards treatment in patients with self-reported psoriasis, including those with co-morbid PsA. Respondents were recruited through patient panels. The survey included questions relating to treatment goals; patients were provided with a choice of answer statements. Patient satisfaction was rated on a 7-point scale (1=extremely dissatisfied; 7=extremely satisfied). RESULTS : Overall, 13% (296/2361) respondents from 22 countries had patient-reported psoriasis and co-morbid PsA. When this subset started their current treatment (biologic therapy for 55%), 181 patients (61%) reported setting treatment goals with their physician. Of those without treatment goals (n=115), 17% reported pro-actively asking to set goals but this had not happened (n=15) or was refused (n=4). Of the 181 patients with treatment goals, 84% reported having some input in goal setting: 40% reported having equal input with their physician, 34% reported some input although their physician mainly set the goals, while 10% mainly/solely set the goals themselves. However, 33% with treatment goals reported that their goals did not meet expectations. Mean [SD] satisfaction with level of involvement in goal setting was 5.1 [1.4] for all PsA patients (5.4 [1.2] and 4.6 [1.6] for those taking and not taking biologic therapy, respectively) and satisfaction with the goals set was 5.1 (1.6) for all with PsA (5.4 [1.4] and 4.5 [1.7] for those taking and not taking biologic therapy, respectively). CONCLUSIONS : These results show approximately two-thirds of this subset of patients with PsA did set treatment goals, with the majority having input in goal setting. Despite this, approximately one-third of patients with treatment goals felt unsatisfied with the goals that were set.
Conference/Value in Health Info
2020-11, ISPOR Europe 2020, Milan, Italy
Value in Health, Volume 23, Issue S2 (December 2020)
Code
PMS71
Topic
Patient-Centered Research
Topic Subcategory
Stated Preference & Patient Satisfaction
Disease
Musculoskeletal Disorders